EGFR and hepatocellular carcinoma: A series of in vitro and in vivo experiments validated that overexpressed METTL1 is involved in lenvatinib resistance and promotion of proliferation capacity of lenvatinib-resistant HCC cells by elevating the translation of EGFR [77].